Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region.
Kumar P, Vuyyuru SK, Kante B, Sahu P, Goyal S, Madhu D, Jain S, Ranjan MK, Mundhra S, Golla R, Singh M, Virmani S, Gupta A, Yadav N, Kalaivani M, Sharma R, Das P, Makharia G, Kedia S, Ahuja V. Kumar P, et al. Among authors: golla r. Aliment Pharmacol Ther. 2022 Jun;55(11):1431-1440. doi: 10.1111/apt.16839. Epub 2022 Mar 1. Aliment Pharmacol Ther. 2022. PMID: 35229906
Minimal risk of lymphoma and non-melanoma skin cancer despite long-term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.
Ranjan MK, Kante B, Vuyyuru SK, Kumar P, Mundhra SK, Golla R, Sharma R, Sahni P, Das P, Makharia G, Kedia S, Ahuja V. Ranjan MK, et al. Among authors: golla r. J Gastroenterol Hepatol. 2022 Aug;37(8):1544-1553. doi: 10.1111/jgh.15880. Epub 2022 May 10. J Gastroenterol Hepatol. 2022. PMID: 35501287
Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis.
Kumar P, Vuyyuru SK, Kante B, Kedia S, Sahu P, Ranjan MK, Mundhra S, Golla R, Kumar M, Virmani S, Gupta A, Yadav N, Makharia G, Ahuja V. Kumar P, et al. Among authors: golla r. Indian J Gastroenterol. 2022 Oct;41(5):446-455. doi: 10.1007/s12664-022-01252-5. Epub 2022 Nov 15. Indian J Gastroenterol. 2022. PMID: 36378484
Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring.
Kumar P, Vuyyuru SK, Das P, Kante B, Ranjan MK, Thomas DM, Mundhra S, Sahu P, Venigalla PM, Jain S, Goyal S, Golla R, Virmani S, Singh MK, Sachdeva K, Sharma R, Dash NR, Makharia G, Kedia S, Ahuja V. Kumar P, et al. Among authors: golla r. Intest Res. 2023 Oct;21(4):460-470. doi: 10.5217/ir.2022.00128. Epub 2023 Mar 17. Intest Res. 2023. PMID: 36926698 Free PMC article.
Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis.
Ranjan MK, Kumar P, Vuyyuru SK, Kante B, Mundhra SK, Golla R, Virmani S, Sharma R, Sahni P, Das P, Kalaivani M, Upadhyay AD, Makharia G, Kedia S, Ahuja V. Ranjan MK, et al. Among authors: golla r. J Crohns Colitis. 2024 Feb 26;18(2):192-203. doi: 10.1093/ecco-jcc/jjad135. J Crohns Colitis. 2024. PMID: 37584328
85 results